Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of the NULISAseq Neuro 220 Panel with ...

New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from ...

Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...

Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and biomarker discovery in proteomics.

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

GLP-1 drugs have revolutionized the treatment of diabetes and obesity, but hurdles remain to their more widespread use. A study led by biochemist Henry Daniell of the School of Dental Medicine at the ...

The layoffs cut into The Post’s local, international and sports coverage, and reduced its entire work force by about 30 percent. Matt Murray, executive editor of The Washington Post, told employees ...

Abstract: Lysine post-translational modification (PTM) is involved in almost all cellular activities, and plays a critical role in protein structure and function. In the past decades, a variety of ...

A molecular model showing three of the main epigenetic modifications of DNA (orange) and histones (dark blue) [JUAN GAERTNER/Science Photo Library/Getty Images] Post-translational modifications (PTMs) ...

Lysine post-translational modifications (PTMs) are crucial for regulating protein function, yet their experimental identification remains challenging. To address this, we developed an AI framework ...